Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients

Mostrar otras versiones (1)

Correction to Gupta P K, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Journal of Neuroinflammation 8:47.

Detalles Bibliográficos
Autores principales: Gupta, Pawan K, Prabhakar, Sudesh, Sharma, Suresh, Anand, Akshay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199788/
http://dx.doi.org/10.1186/1742-2094-8-97
_version_ 1782214596615995392
author Gupta, Pawan K
Prabhakar, Sudesh
Sharma, Suresh
Anand, Akshay
author_facet Gupta, Pawan K
Prabhakar, Sudesh
Sharma, Suresh
Anand, Akshay
author_sort Gupta, Pawan K
collection PubMed
description Correction to Gupta P K, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Journal of Neuroinflammation 8:47.
format Online
Article
Text
id pubmed-3199788
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31997882011-10-25 Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients Gupta, Pawan K Prabhakar, Sudesh Sharma, Suresh Anand, Akshay J Neuroinflammation Correction Correction to Gupta P K, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Journal of Neuroinflammation 8:47. BioMed Central 2011-08-11 /pmc/articles/PMC3199788/ http://dx.doi.org/10.1186/1742-2094-8-97 Text en Copyright ©2011 Gupta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correction
Gupta, Pawan K
Prabhakar, Sudesh
Sharma, Suresh
Anand, Akshay
Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients
title Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients
title_full Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients
title_fullStr Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients
title_full_unstemmed Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients
title_short Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients
title_sort vascular endothelial growth factor-a (vegf-a) and chemokine ligand-2 (ccl2) in amyotrophic lateral sclerosis (als) patients
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199788/
http://dx.doi.org/10.1186/1742-2094-8-97
work_keys_str_mv AT guptapawank vascularendothelialgrowthfactoravegfaandchemokineligand2ccl2inamyotrophiclateralsclerosisalspatients
AT prabhakarsudesh vascularendothelialgrowthfactoravegfaandchemokineligand2ccl2inamyotrophiclateralsclerosisalspatients
AT sharmasuresh vascularendothelialgrowthfactoravegfaandchemokineligand2ccl2inamyotrophiclateralsclerosisalspatients
AT anandakshay vascularendothelialgrowthfactoravegfaandchemokineligand2ccl2inamyotrophiclateralsclerosisalspatients

Ejemplares similares